American Portfolios Advisors United Therapeutics Corp Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in United Therapeutics Corp stock. As of the latest transaction made, American Portfolios Advisors holds 83 shares of UTHR stock, worth $29,743. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83
Holding current value
$29,743
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$203.3 - $244.17 $16,873 - $20,266
83 New
83 $17.4 Million
Q2 2022

Mar 20, 2023
SELL
$174.81 - $241.14 $13,110 - $18,085
-75 Reduced 90.36%
8 $1.89 Million
Q1 2022

Mar 21, 2023
SELL
$166.16 - $213.96 $12,462 - $16,047
-75 Reduced 90.36%
8 $1.44 Million
Q4 2021

Mar 21, 2023
SELL
$184.32 - $216.08 $13,824 - $16,206
-75 Reduced 90.36%
8 $1.73 Million
Q3 2021

Mar 22, 2023
SELL
$179.86 - $214.88 $13,489 - $16,116
-75 Reduced 90.36%
8 $1.48 Million
Q2 2021

Mar 22, 2023
SELL
$170.47 - $211.93 $12,785 - $15,894
-75 Reduced 90.36%
8 $1.44 Million
Q1 2021

Mar 22, 2023
SELL
$153.94 - $174.85 $11,237 - $12,764
-73 Reduced 87.95%
10 $1.67 Million
Q4 2019

Mar 24, 2023
SELL
$78.31 - $95.34 $2,584 - $3,146
-33 Reduced 39.76%
50 $4.4 Million
Q2 2019

Mar 24, 2023
SELL
$76.06 - $120.81 $2,509 - $3,986
-33 Reduced 39.76%
50 $3.9 Million
Q3 2018

Mar 24, 2023
SELL
$113.81 - $129.46 $3,755 - $4,272
-33 Reduced 39.76%
50 $6.39 Million
Q1 2018

Mar 24, 2023
SELL
$107.21 - $151.94 $3,537 - $5,014
-33 Reduced 39.76%
50 $5.62 Million
Q4 2017

Mar 24, 2023
SELL
$118.58 - $151.28 $3,913 - $4,992
-33
50 $7.4 Million

Others Institutions Holding UTHR

# of Institutions
619
Shares Held
45M
Call Options Held
368K
Put Options Held
410K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email